Medicare Enrolled
Dr. Fanping Wang, M.D
Cardiovascular Disease · Oxnard, CA
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Fanping Wang is a cardiovascular disease specialist in Oxnard, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 7,913 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wang received a total of $16,345 from 42 pharmaceutical and/or device companies across 925 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in CA
$16,345 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,913
Medicare services
Top 10% in CA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,112 | $101 | $175 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
897 | $41 | $114 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
788 | $34 | $95 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
762 | $12 | $66 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
572 | $43 | $123 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
492 | $54 | $145 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
452 | $42 | $88 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
425 | $137 | $775 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
333 | $47 | $120 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
290 | $100 | $388 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 214 | $417 | $1,000 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
203 | $18 | $65 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
148 | $30 | $163 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
148 | $13 | $169 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
127 | $20 | $80 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
113 | $62 | $372 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
90 | $206 | $998 |
| CT scan of heart blood vessels and grafts with contrast A CT scan that uses contrast dye to create detailed images of the heart's blood vessels and any surgical grafts. |
81 | $94 | $350 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
77 | $124 | $400 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
76 | $1,746 | $3,500 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
73 | $178 | $660 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $132 | $280 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
58 | $88 | $250 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
53 | $22 | $90 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
50 | $31 | $120 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
49 | $20 | $45 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
28 | $170 | $570 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
27 | $1,342 | $4,000 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
27 | $11 | $35 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
27 | $22 | $60 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
23 | $70 | $140 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $141 | $300 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
12 | $11 | $35 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
12 | $20 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.8% high complexity
13.6% medium
77.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,345
Total received (2018-2024)
Avg $2,335/year across 7 years
Top 21% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
925
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,193
2023
$1,876
2022
$2,381
2021
$3,014
2020
$1,863
2019
$2,455
2018
$2,564
Payments by company (2024)
PFIZER INC.
$365
Abbott Laboratories
$184
Novartis Pharmaceuticals Corporation
$176
Lexicon Pharmaceuticals, Inc.
$166
Amgen Inc.
$164
AstraZeneca Pharmaceuticals LP
$164
HEARTFLOW, INC.
$159
E.R. Squibb & Sons, L.L.C.
$139
Boston Scientific Corporation
$129
Kiniksa Pharmaceuticals International, plc
$111
Merck Sharp & Dohme LLC
$110
Novo Nordisk Inc
$89
Janssen Pharmaceuticals, Inc
$52
Alnylam Pharmaceuticals Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$33
Edwards Lifesciences Corporation
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
AltaThera Pharmaceuticals LLC
$21
iRhythm Technologies, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$18
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,212
AstraZeneca Pharmaceuticals LP
$1,908
Novartis Pharmaceuticals Corporation
$1,618
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,356
Janssen Pharmaceuticals, Inc
$1,332
Amarin Pharma Inc.
$1,036
PFIZER INC.
$881
E.R. Squibb & Sons, L.L.C.
$717
Abbott Laboratories
$615
SANOFI-AVENTIS U.S. LLC
$548
Boehringer Ingelheim Pharmaceuticals, Inc.
$464
Merck Sharp & Dohme LLC
$398
Gilead Sciences, Inc.
$361
Boston Scientific Corporation
$328
Allergan Inc.
$274
Alnylam Pharmaceuticals Inc.
$201
Merck Sharp & Dohme Corporation
$178
Esperion Therapeutics, Inc.
$177
Kiniksa Pharmaceuticals, Ltd.
$176
Edwards Lifesciences Corporation
$169
Lexicon Pharmaceuticals, Inc.
$166
HEARTFLOW, INC.
$159
Novo Nordisk Inc
$143
Actelion Pharmaceuticals US, Inc.
$120
Kiniksa Pharmaceuticals International, plc
$111
Regeneron Healthcare Solutions, Inc.
$106
Kowa Pharmaceuticals America, Inc.
$105
Otsuka America Pharmaceutical, Inc.
$81
iRhythm Technologies, Inc.
$74
HeartFlow, Inc.
$71
Medtronic, Inc.
$39
Bayer HealthCare Pharmaceuticals Inc.
$38
Lundbeck LLC
$25
BIOTRONIK INC.
$23
Kestra Medical Technology Services, Inc.
$22
AltaThera Pharmaceuticals LLC
$21
AngioDynamics, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$17
BOSTON SCIENTIFIC CORPORATION
$16
Relypsa, Inc.
$15
Philips Electronics North America Corporation
$14
Medtronic Vascular, Inc.
$11
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · AMPLATZER AMULET · ANDEXXA · AVEIR · Accent Pacemaker · Adempas · Arcalyst · Assure WCD · BRILINTA · BYDUREON · BYSTOLIC · BYVALSON · CAMZYOS · CHANTIX · Confirm Rx · CoreValve Evolut · Corlanor · Dragonfly OCT · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · HeartMate 3 Left Ventricular Dev · Inpefa · JARDIANCE · LEQVIO · LifeVest · Livalo · MULTAQ · Micra · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Repatha · Reveal XT · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · Sotalol Hydrochloride · TEPEZZA · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
45
County median income
$107,327
Nearest hospital to ZIP centroid (approximate)
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wang is a remote & cardiac specialist, with above-average Medicare volume (top 10% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wang performed 1,112 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $16,345 from 42 companies across 925 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other cardiologists in Oxnard?
Dr. Wang's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Oxnard
Browse cardiologists in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology